Literature DB >> 23816428

The social impact of Parkinson's disease in Spain: Report by the Spanish Foundation for the Brain.

R García-Ramos1, E López Valdés2, L Ballesteros3, S Jesús4, P Mir4.   

Abstract

INTRODUCTION: Understanding the social and economic impact of Parkinson's disease is essential for resource planning and raising social awareness. DEVELOPMENT: Researchers reviewed the data published to date on epidemiology, morbidity and mortality, dependency, and economic impact of Parkinson's disease in Spain. In addition, a study has been carried out in order to define the public and private health care resources of Spanish patients affected by Parkinson's disease by means of an e-mail survey of all neurologists specialising in this disease and belonging to the Spanish Society of Neurology's study group for movement disorders.
CONCLUSIONS: The incidence and prevalence rates of Parkinson's disease in Spain are similar to those in the rest of Europe. According to current population estimates, there are at least 300.000 patients with Parkinson's disease and one new case per 10.000 habitants per year in Spain. This has a major impact on the patient's quality of life and nearly doubles patient mortality. In addition, the disease generates sizeable costs for the country that may exceed 17.000€ per year per patient; costs will rise due to the ageing of the population and the new therapies employed. Healthcare professionals and administrators dedicate their efforts to providing quality care to patients. Despite the above, we still have a long way to go in order to provide quality, efficient, multidisciplinary, and universal healthcare.
Copyright © 2013 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Calidad de vida; Economic impact; Enfermedad de Parkinson; Epidemiology; Epidemiología; España; Impacto económico; Mortalidad; Mortality; Parkinson's disease; Quality of life; Spain

Mesh:

Year:  2013        PMID: 23816428     DOI: 10.1016/j.nrl.2013.04.008

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  9 in total

1.  Spanish version of the Parkinson's Disease Questionnaire-Carer (PDQ-Carer).

Authors:  Rosario Ferrer-Cascales; María José Cabañero-Martínez; Miriam Sánchez-SanSegundo; Nereida Congost-Maestre; Crispin Jenkinson
Journal:  Health Qual Life Outcomes       Date:  2016-11-04       Impact factor: 3.186

2.  Parkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model Analysis.

Authors:  Pablo Martinez-Martín; Carmen Rodriguez-Blazquez; Silvia Paz; Maria João Forjaz; Belén Frades-Payo; Esther Cubo; Jesús de Pedro-Cuesta; Luis Lizán
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

3.  Effectiveness of Serious Games for Leap Motion on the Functionality of the Upper Limb in Parkinson's Disease: A Feasibility Study.

Authors:  Edwin Daniel Oña; Carlos Balaguer; Roberto Cano-de la Cuerda; Susana Collado-Vázquez; Alberto Jardón
Journal:  Comput Intell Neurosci       Date:  2018-04-11

4.  Benefits of Pilates in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  David Suárez-Iglesias; Kyle J Miller; Manuel Seijo-Martínez; Carlos Ayán
Journal:  Medicina (Kaunas)       Date:  2019-08-13       Impact factor: 2.430

5.  Evolution of Quality of Life in Persons with Parkinson's Disease: A Prospective Cohort Study.

Authors:  Eduardo Candel-Parra; María Pilar Córcoles-Jiménez; Victoria Delicado-Useros; Antonio Hernández-Martínez; Milagros Molina-Alarcón
Journal:  J Clin Med       Date:  2021-04-22       Impact factor: 4.241

6.  Relationship between Motor and Nonmotor Symptoms and Quality of Life in Patients with Parkinson's Disease.

Authors:  Eduardo Candel-Parra; María Pilar Córcoles-Jiménez; Victoria Delicado-Useros; Antonio Hernández-Martínez; Milagros Molina-Alarcón
Journal:  Nurs Rep       Date:  2021-12-24

7.  Adopting a multidisciplinary telemedicine intervention for fall prevention in Parkinson's disease. Protocol for a longitudinal, randomized clinical trial.

Authors:  Esther Cubo; Alvaro Garcia-Bustillo; Alvar Arnaiz-Gonzalez; Jose Miguel Ramirez-Sanz; Jose Luis Garrido-Labrador; Florita Valiñas; Marta Allende; Jeronimo Javier Gonzalez-Bernal; Josefa Gonzalez-Santos; José Francisco Diez-Pastor; Maha Jahouh; Jana Arribas; Jose Trejo
Journal:  PLoS One       Date:  2021-12-21       Impact factor: 3.240

8.  The Impact of Depression Symptoms in Patients with Parkinson's Disease: A Novel Case-Control Investigation.

Authors:  Ana María Jiménez-Cebrián; Ricardo Becerro-de-Bengoa-Vallejo; Marta Elena Losa-Iglesias; Daniel López-López; César Calvo-Lobo; Patricia Palomo-López; Carlos Romero-Morales; Emmanuel Navarro-Flores
Journal:  Int J Environ Res Public Health       Date:  2021-03-01       Impact factor: 3.390

9.  Predictive Model of Quality of Life in Patients with Parkinson's Disease.

Authors:  Eduardo Candel-Parra; María Pilar Córcoles-Jiménez; Victoria Delicado-Useros; Marta Carolina Ruiz-Grao; Antonio Hernández-Martínez; Milagros Molina-Alarcón
Journal:  Int J Environ Res Public Health       Date:  2022-01-07       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.